← Back to headlines
Beeline Ups Series A Round for Immune Drug Work
Beeline has increased its Series A funding round to further its research and development efforts in immune drug work.
30 Jun, 10:22 — 30 Jun, 10:22
Sources
Showing 1 of 1 sources
Beeline has increased its Series A funding round to further its research and development efforts in immune drug work.
